ALS INHIBITOR VON RETROVIRALER PROTEASE GEEIGNETE RITONAVIR-ANALOGE VERBINDUNG, HERSTELLUNG DER RITONAVIR-ANALOGEN VERBINDUNG UND PHARMAZEUTISCHE ZUSAMMENETZUNG FÜR DIE RITONAVIR-ANALOGE VERBINDUNG

ALS INHIBITOR VON RETROVIRALER PROTEASE GEEIGNETE RITONAVIR-ANALOGE VERBINDUNG, HERSTELLUNG DER RITONAVIR-ANALOGEN VERBINDUNG UND PHARMAZEUTISCHE ZUSAMMENETZUNG FÜR DIE RITONAVIR-ANALOGE VERBINDUNG

The present invention describes a new one ritonavir analogous compound that presents significantly superior activity in inhibition of HIV protease. There are also described the usage of the ritonavir analogous compound of the present invention or salt, ester or prodrug thereof as well as the usage o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BOCKELMANN, MARIA ALICE, FUZETO, CLAUDIO ROBERTO, OLIVEIRA, KESLEY MORAES GODINHO DE, VERNUCCI, THIAGO BOSCARO, ROSATTO, SIMONE SOARES, BAREL, DANIELA CECILIA, FREITAS, MATHEUS PUGGINA DE
Format: Patent
Sprache:ger
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention describes a new one ritonavir analogous compound that presents significantly superior activity in inhibition of HIV protease. There are also described the usage of the ritonavir analogous compound of the present invention or salt, ester or prodrug thereof as well as the usage of the compound and its pharmaceutical compositions in medicine, particularly, in the treatment of HIV infection, by itself or in combination with others anti-HIV drugs.